Stay updated on Pembrolizumab in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page shows a new Revision: v3.6.4 label, replacing the previous Revision: v3.6.3, indicating a minor system update to the page's version labeling.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, reflecting a new release version of the page. This change indicates a small update to the page's underlying software or documentation without modifying study information.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page now shows a new revision tag v3.6.2 and the older tag v3.6.0 has been removed, updating the page's version indicator.SummaryDifference0.1%

- Check50 days agoChange DetectedThe study page now marks recruitment as closed with the note 'No longer looking for participants', signaling that no further participant enrollment is expected. Additionally, new help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), and a formatting change was made to the Intervention/Treatment heading.SummaryDifference0.4%

- Check57 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4. This indicates the page has been updated to a newer version.SummaryDifference0.1%

- Check78 days agoChange DetectedNew revision label Revision: v3.5.4 has been added, replacing the earlier Revision: v3.5.3, indicating an updated page/document version. This update records a versionchange without altering the substantive content shown to users.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.